428 related articles for article (PubMed ID: 9066231)
1. The pharmacologic management of obesity.
Cerda JJ
J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
[No Abstract] [Full Text] [Related]
2. Pharmacologic therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
[TBL] [Abstract][Full Text] [Related]
3. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
4. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).
Shyh G; Cheng-Lai A
Cardiol Rev; 2014; 22(1):43-50. PubMed ID: 24304809
[TBL] [Abstract][Full Text] [Related]
5. [A drug help in reducing? Risk profile decides whether and how].
Hauner H
MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
[No Abstract] [Full Text] [Related]
6. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
Steel JM; Munro JF; Duncan LJ
Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
[No Abstract] [Full Text] [Related]
7. New agent for obesity management.
Clemenson ND
J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
[No Abstract] [Full Text] [Related]
8. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
Bays HE; Gadde KM
Drugs Today (Barc); 2011 Dec; 47(12):903-14. PubMed ID: 22348915
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
[TBL] [Abstract][Full Text] [Related]
10. Medications for weight reduction.
Bray GA
Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704
[TBL] [Abstract][Full Text] [Related]
11. The treatment of obesity. A call for prudence and professionalism.
Kushner R
Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914
[No Abstract] [Full Text] [Related]
12. Appetite suppressants for obesity.
Budenholzer B
J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
[No Abstract] [Full Text] [Related]
13. Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.
Rubio MA
Endocrinol Nutr; 2014 Dec; 61(10):501-4. PubMed ID: 25434595
[No Abstract] [Full Text] [Related]
14. Two new drugs approved for obesity.
Johnson AM
S D Med; 2012 Sep; 65(9):356-7. PubMed ID: 23066610
[No Abstract] [Full Text] [Related]
15. After fen-phen.
Cowley G; Springen K
Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
[No Abstract] [Full Text] [Related]
16. [What effect does losing weight have on hypertension?].
Engeli S
MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
[No Abstract] [Full Text] [Related]
17. Bitter pills, bad medicine.
Golden F
Time; 2001 Jun; 157(22):76. PubMed ID: 11432381
[No Abstract] [Full Text] [Related]
18. Pharmacotherapy for the obese patient.
Dickerson LM; Carek PJ
Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251
[TBL] [Abstract][Full Text] [Related]
19. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Truant AP; Olon LP; Cobb S
Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
[No Abstract] [Full Text] [Related]
20. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
